Biolife Solutions BLFS
NASDAQ BLFS
$37.10 +0.13 (+0.35%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biolife Solutions (BLFS) Long-Term Deferred Tax (2010 - 2026)

Biolife Solutions (BLFS) posted quarterly Long-Term Deferred Tax of $7.4 million for Q4 2018, down 9.57% year-over-year from $8.2 million in Q4 2017, and down 9.57% quarter-over-quarter from $8.2 million in Q4 2017.

Biolife Solutions (BLFS) Long-Term Deferred Tax (2010 - 2026) Analysis & Trends

Biolife Solutions (BLFS) has reported Long-Term Deferred Tax for 6 consecutive years, with $7.4 million the latest figure, recorded in Q4 2018.

  • In Q4 2018, Long-Term Deferred Tax fell 9.57% year-over-year to $7.4 million; the TTM figure through Dec 2018 stood at $7.4 million (down 9.57% YoY), while the FY2018 annual figure was $7.4 million, down 9.57% from the prior year.
  • Long-Term Deferred Tax slipped to $7.4 million in Q4 2018 per BLFS's latest filing, from $8.2 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $8.2 million in Q4 2017 and bottomed at $7.4 million in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn
10 Biolife Solutions 1.82 Bn 1.73 Bn 18.29 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 42.23 Mn
Dec 31, 2018 7.38 Mn
Dec 31, 2017 8.16 Mn
Dec 31, 2013 114,874.00
Jun 30, 2013 143,399.00
Mar 31, 2013 157,506.00
Dec 31, 2012 171,458.00
Sep 30, 2012 189,855.00
Jun 30, 2012 208,251.00
Mar 31, 2012 84,997.00
Dec 31, 2011 112,042.00
Sep 30, 2011 139,384.00
Jun 30, 2011 70,466.00
Dec 31, 2010 97,220.00